Study shows value-based plans can improve adherence for diabetes medicines
A study by CVS Caremark (NYSE: CVS), published this week in the American Journal of Pharmacy Benefits, finds that insurance benefit designs that reduce the cost of medications for plan participants result in patients being more likely to start and stay on their medication therapy.
Leave a Response
You must be logged in to post a comment.
